ATM is a target for positive regulation by E2F-1

被引:100
|
作者
Berkovich, E [1 ]
Ginsberg, D [1 ]
机构
[1] Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel
关键词
E2F; ATM; oncogenic stress;
D O I
10.1038/sj.onc.1206144
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The E2F-1 transcription factor is a critical downstream target of the tumor suppressor, RB. When activated, E2F-1 induces cell proliferation. In addition, deregulation of E2F-1 constitutes an oncogenic stress that can induce apoptosis. The protein kinase ATM is a pivotal mediator of the response to another type of stress, genotoxic stress. In response to ionizing radiation, ATM activates the tumor suppressor p53, a key player in the control of cell growth and viability. We show here that E2F-1 elevates ATM promoter activity and induces an increase in ATM mRNA and protein levels. This is accompanied by an E2F-nduced increase in p53 phosphorylation. Expression of the E7 protein of HPV16, which dissociates RB/E2F complexes, also induces the elevation of ATM levels and p53 phosphorylation, implicating endogenous E2F in these phenomena. These data demonstrate that ATM is transcriptionally regulated by E2F-1 and suggest that ATM serves as a novel, ARF-independent functional link between the RB/E2F pathway and p53.
引用
收藏
页码:161 / 167
页数:7
相关论文
共 50 条
  • [1] ATM is a target for positive regulation by E2F-1
    Eli Berkovich
    Doron Ginsberg
    Oncogene, 2003, 22 : 161 - 167
  • [2] E2F-1 as an anticancer drug target
    Bertino, Joseph R.
    Banerjee, Debabrata
    ONCOLOGY REVIEWS, 2009, 3 (04) : 207 - 214
  • [3] Positive regulation of ataxia-telangiectasia-mutated protein (ATM) by E2F transcription Factor 1 (E2F-1) in cisplatin-resistant nasopharyngeal carcinoma cells
    Zun-Yan Zhou
    Ji-Yuan Yang
    Cheng-Ze Shao
    Fei Luo
    Wei Du
    World Journal of Surgical Oncology, 20
  • [4] Positive regulation of ataxia-telangiectasia-mutated protein (ATM) by E2F transcription Factor 1 (E2F-1) in cisplatin-resistant nasopharyngeal carcinoma cells
    Zhou, Zun-Yan
    Yang, Ji-Yuan
    Shao, Cheng-Ze
    Luo, Fei
    Du, Wei
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2022, 20 (01)
  • [5] Interaction between ubiquitin–protein ligase SCFSKP2 and E2F-1 underlies the regulation of E2F-1 degradation
    A. Marti
    C. Wirbelauer
    M. Scheffner
    W. Krek
    Nature Cell Biology, 1999, 1 : 14 - 19
  • [6] Association of Purα and E2F-1 suppresses transcriptional activity of E2F-1
    Darbinian, N
    Gallia, GL
    Kundu, M
    Shcherbik, N
    Tretiakova, A
    Giordano, A
    Khalili, K
    ONCOGENE, 1999, 18 (46) : 6398 - 6402
  • [7] Association of Purα and E2F-1 suppresses transcriptional activity of E2F-1
    Nune Darbinian
    Gary L Gallia
    Mondira Kundu
    Natalia Shcherbik
    Anna Tretiakova
    Antonio Giordano
    Kamel Khalili
    Oncogene, 1999, 18 : 6398 - 6402
  • [8] Arginine methylation controls growth regulation by E2F-1
    Cho, Er-Chieh
    Zheng, Shunsheng
    Munro, Shonagh
    Liu, Geng
    Carr, Simon M.
    Moehlenbrink, Jutta
    Lu, Yi-Chien
    Stimson, Lindsay
    Khan, Omar
    Konietzny, Rebecca
    McGouran, Joanna
    Coutts, Amanda S.
    Kessler, Benedikt
    Kerr, David J.
    La Thangue, Nicholas B.
    EMBO JOURNAL, 2012, 31 (07): : 1785 - 1797
  • [9] Regulation of E2F-1 gene expression in avian cells
    Xavier Espanel
    Laurent Le Cam
    Sophie North
    Claude Sardet
    Gilbert Brun
    Germain Gillet
    Oncogene, 1998, 17 : 585 - 594
  • [10] Regulation of E2F-1 gene expression in avian cells
    Espanel, X
    Le Cam, L
    North, S
    Sardet, C
    Brun, G
    Gillet, G
    ONCOGENE, 1998, 17 (05) : 585 - 594